| Tag | Content |
|---|
EnhancerAtlas ID | HS091-16032 |
Organism | Homo sapiens |
Tissue/cell | HepG2 |
Coordinate | chr16:2609650-2611480 |
TF binding sites/motifs | | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
| CTCF | MA0139.1 | chr16:2610925-2610944 | TGGCTCCCTCTTGTGGGCA | - | 6 | | SPI1 | MA0080.4 | chr16:2610351-2610365 | CACTTCCCCTTTCT | - | 6.22 | | SPIB | MA0081.2 | chr16:2610351-2610363 | CACTTCCCCTTT | - | 6.07 | | SPIC | MA0687.1 | chr16:2610253-2610267 | TTCTTCCTCTTTTC | - | 6.47 | | ZNF263 | MA0528.1 | chr16:2610621-2610642 | TCCTCTGCTCCCTGCTCCTCA | - | 6.07 |
|
| | Number of super-enhancer constituents: 5 | ID | Coordinate | Tissue/cell |
| SE_04176 | chr16:2609559-2613501 | Brain_Anterior_Caudate | | SE_06480 | chr16:2609260-2613955 | Brain_Hippocampus_Middle | | SE_09737 | chr16:2606476-2612713 | CD14 | | SE_12984 | chr16:2609368-2610909 | CD34_Primary_RO01480 | | SE_13470 | chr16:2608927-2611886 | CD34_Primary_RO01536 |
|
| | Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | | Number of disease enhancers: 1 | Chromosome | Start | End |
|
| | Number: 1 | ID | Chromosome | Start | End |
| GH16I002559 | chr16 | 2609750 | 2611232 |
|
Enhancer Sequence | CACCTGGGCT TAAGCGATCC TCCTGCCTTA GCCTCCTGAG TAGCTGGGAC CACAGGCATG 60
TGCCACCATA CATGGCCCTT AACATTTATC TTGACTGAAA AAGGAAGACT CATCTGTGAA 120
ATTGCCTGTT TCCCTGGGTT CTGGAGATGG GTGGAGAGCA GGCACTGTCC CTCCAGGGGC 180
TGTGGTCCGT GTCTTTCTGA ACCTGCACCA GGGAGGTGCC CGGGAGAGCA CGGTGAGCCG 240
GAGGCTCCTC CATGGGGCTG TTTGGAATCC ACAGTACTGG GTCTCAGATT ACATGTGTTA 300
CCCTCAGTTC TTTCTCAGCT TTCCTGAAAT GGAGATCACA TAAAAGTTGA TTTCCAGGGG 360
AGGGGGAAAG GACAGTGATA GGAGGCTGGG CAAGAGCCAG CTGCAGCACC GGAGAGCCGG 420
GAGGCCCCCT GAGGACGGTC ACAACCTCCA GGGAGGGACA CGTCACGCGC CATTCTCTGG 480
AAGAGGATCC TTCCTTCTTG TAGGAAACCT GCTTGTGAAG TGTTGAGTTT AGACAACGGA 540
AAGATCACAT CAGTATCCCC TTAGAAAGGG TTCCACTAAA TATCGGTGCT CGTTCACAAT 600
TCTTTCTTCC TCTTTTCTAC TTATGAAGCT AGCACGTGCT CTTGTGGAGA AACGTGACCT 660
CACAGAAACA CATGAGCTAG AGAGGGGAGC CCTGCCCGGC CCACTTCCCC TTTCTCCCTG 720
GCAGCTGAGA GCCATCCATG CGTGGCGTAT TCCTCTGGGA AGACCTTGAG TATGTAGAGT 780
CCCCAGAATC CAACTTCATT CTTCTTGAGT GCCACAAGGC GTCTCACATG GTGCTTTCCA 840
GGATCTCTTC TGACGTGTCC CATCAGGAGT CCTGCCCCGA TTGCGGCTCA CAGCCCGGGG 900
CCAGGTGGAC CTGGCCCTGT GGCCTCCTGA AGGTCTTCCT GCCAGCCCCC AGGAATGTCA 960
CGGGACAGGT TTCCTCTGCT CCCTGCTCCT CAGGCCGTCC CCCTGTGGGT GTCTTAGGAG 1020
ACACTTGTGT CCCACTTGGT GGTGGTGGGG CCTCCCTGGC ACAGCTGCCT CATGCTCTCT 1080
GGCTAAACCG TGGGCCCACC AGGAATCTCC AGTCTGGTGC CTCAGGGTGT GCCCCAGGCT 1140
AGTCCGAGTG GAGGGTCTCT CCCCTGTTTG GGATGCCTGC CCTGCTGGAG TGCTCTGTCT 1200
CGGAGGTGGG GTTTGAGTGC AGGGCTCAGG GGTGCTGAGA GGACAGGGCA GGAGGCCTGC 1260
TGCATCCCGG GCAGGTGGCT CCCTCTTGTG GGCACGCAGG GCCATGCATT GCTGGTTTAG 1320
CTCCCTCTGT CCTTTACAGC CAGGCTCTCT TCATGGTGCC CACAAGCAAC ATCATACAAA 1380
ATGTATGATA ACAGTTATTT CCAAAAACGA AACTTCAGGG CAGCCTTTGC AATGAATGTA 1440
TACTAGAAGG ACATATTGTT GTCACAGAAG CCCCTGTGCC CTGCCACTTG TGGTGGCGCC 1500
ACTGTCTTCC TTCTGTTGGT GAAGGGCGTG GCAGTCGAAG AGGTTCCTGA GTTTGTACTT 1560
GTGTTGCACC GTTAGGGCTG TTAGCAGCTG ATCCAGAAGC TTCTGGAAAC AACAGAGAGA 1620
TGGATATGTT TTCTCTTAGC TGTTAGAACA CATCAACACG AGCATTGGCT TTTAGCTCTA 1680
CTTGTCAGTA CAAGACCCAA AATATTTCAC TGTAGACTCA AGCCTTCAGT GGGGACAGGA 1740
AGCGTGCGTG TGGGGCAGAG GGACTCGTCA GGCCCAGTGT CCTGGTTATT ACATTGTGTG 1800
TTTCTTTTTC TCCTTTTCTT TCCCAACCAG 1830
|
